Urologic Diseases  >>  pioglitazone  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pioglitazone / Generic mfg.
NCT00368017: Metabolic Effects of Thiazolidinediones in Chronic Kidney Disease

Terminated
2
12
US
pioglitazone, ACTOS, placebo
Vanderbilt University
Chronic Kidney Disease
09/07
09/07
PIOren, NCT00770640 / 2007-006744-21: Efficacy of Pioglitazone and Insulin in Treating Subjects With Type 2 Diabetes Mellitus and Renal Failure.

Completed
2
40
Europe
Pioglitazone and insulin, ACTOS®, AD-4833, Insulin
Takeda
Diabetes Mellitus
06/10
06/10
NCT01043029 / 2009-012270-12: A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal Impairment

Checkmark ADA 2013
Jun 2013 - Jun 2013: ADA 2013
Checkmark Effect on cardiovascular risk factor
Mar 2013 - Mar 2013: Effect on cardiovascular risk factor
Completed
2
302
Europe, RoW
aleglitazar, pioglitazone
Hoffmann-La Roche
Diabetes Mellitus Type 2
07/12
07/12
INSPIRED, NCT02278562: Nutrition, Inflammation and Insulin Resistance in End Stage Renal Disease-Aim 2

Completed
2
33
US
anakinra, actos, placebo
VA Office of Research and Development
ESRD
03/17
03/17

Download Options